Palisade Bio (PALI) News Today $4.24 +0.10 (+2.42%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 19, 2024 | finanznachrichten.dePalisade Bio, Inc.: Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108July 19, 2024 | globenewswire.comPalisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108July 11, 2024 | globenewswire.comPalisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug ProductJune 24, 2024 | globenewswire.comPalisade Bio to Participate in the Virtual Investor Closing Bell SeriesJune 21, 2024 | globenewswire.comPalisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life SciencesJune 11, 2024 | globenewswire.comPalisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108June 10, 2024 | globenewswire.comPalisade Bio to Present at the Virtual Investor Pitch ConferenceMay 21, 2024 | finance.yahoo.comPalisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse ModelsMay 21, 2024 | globenewswire.comPalisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse ModelsMay 19, 2024 | finance.yahoo.comPalisade Bio, Inc. (PALI)May 17, 2024 | markets.businessinsider.comBuy Rating Affirmed for Palisade Bio’s PALI-2108 Amid Strong Financials and Promising PartnershipMay 14, 2024 | seekingalpha.comPalisade Bio GAAP EPS of -$4.59May 14, 2024 | globenewswire.comPalisade Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | msn.comPALI Stock Earnings: Palisade Bio Beats EPS for Q1 2024May 7, 2024 | globenewswire.comPalisade Bio Appoints Margery Fischbein to its Board of DirectorsMay 7, 2024 | globenewswire.comPalisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesMay 2, 2024 | globenewswire.comPalisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesMay 1, 2024 | msn.comMarijuana reclassified federally in major win for the legal cannabis industryMay 1, 2024 | msn.comPalisade Bio stock rallies 50% premarket on colitis drug updateMay 1, 2024 | finance.yahoo.comPalisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)May 1, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 09:05 AM with a stated reason of "LULD pause."May 1, 2024 | globenewswire.comPalisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)April 23, 2024 | msn.comPalisade Bio, Strand Life Sciences team up on colitis drug researchApril 23, 2024 | msn.comWhy Palisade Bio Stock Is Up TodayApril 23, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 09:04 AM with a stated reason of "LULD pause."April 23, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 09:04 AM with a stated reason of "LULD pause."April 23, 2024 | finance.yahoo.comPalisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine ApproachApril 23, 2024 | globenewswire.comPalisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine ApproachApril 19, 2024 | benzinga.comLooking Into Palisade Bio's Recent Short InterestApril 17, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)April 17, 2024 | msn.comHow Apple Car Key Works (and Why It Still Hasn’t Caught On)April 16, 2024 | msn.comPalisade Bio stock rallies nearly 100% on colitis drug analysisApril 16, 2024 | marketwatch.comPalisade Bio Shares Surge 80% After Lab Study Results for Ulcerative Colitis TreatmentApril 16, 2024 | msn.comWhy Palisade Bio Stock Is Soaring TodayApril 16, 2024 | investorplace.comWhy Is Palisade Bio (PALI) Stock Up 57% Today?April 16, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 09:04 AM with a stated reason of "LULD pause."April 16, 2024 | finance.yahoo.comPalisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ StoolApril 16, 2024 | globenewswire.comPalisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients' StoolApril 12, 2024 | uk.investing.comPalisade Bio advances ulcerative colitis treatment to Phase 1 studyApril 11, 2024 | globenewswire.comPalisade Bio to Participate in the Virtual Investor Lunch Break EventApril 10, 2024 | msn.comPalisade Bio stock slides 8% amid colitis drug presentationApril 10, 2024 | finance.yahoo.comPalisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™April 10, 2024 | globenewswire.comPalisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn's & Colitis™April 8, 2024 | marketbeat.comTrading was temporarily halted for "PALI" at 07:04 PM with a stated reason of "News pending."April 6, 2024 | morningstar.comPalisade Bio Inc 7NSApril 3, 2024 | globenewswire.comPalisade Bio Announces 1-for-15 Reverse Stock SplitMarch 27, 2024 | finance.yahoo.comPalisade Bio Reports Year End 2023 Financial Results and Provides Corporate UpdateMarch 27, 2024 | investorplace.comPALI Stock Earnings: Palisade Bio Beats EPS for Q4 2023February 15, 2024 | finance.yahoo.comPalisade Bio to Present at Digestive Disease Week (DDW) 2024February 15, 2024 | globenewswire.comPalisade Bio to Present at Digestive Disease Week (DDW) 2024 Get Palisade Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter. Email Address The next companies to potentially benefit thanks to Nvidia are … (Ad)Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners. Click here to learn more. PALI Media Mentions By Week PALI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PALI News Sentiment▼0.320.62▲Average Medical News Sentiment PALI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PALI Articles This Week▼22▲PALI Articles Average Week Get Palisade Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PSTV News EVAX News APTO News IKT News SNTI News COEP News CLDI News ONVO News TCBP News FRTX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PALI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palisade Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palisade Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.